Fink U - Search Results

1

Prognostic importance of histomorphologic subclassification for epithelial thymic tumors.

Schneider PM, Fellbaum C, Fink U, Bollschweiler E, Präuer HW. Schneider PM, et al. Among authors: fink u. Ann Surg Oncol. 1997 Jan;4(1):46-56. doi: 10.1007/BF02316810. Ann Surg Oncol. 1997. PMID: 8985517

2

Preoperative staging of gastric cancer as precondition for multimodal treatment.

Sendler A, Dittler HJ, Feussner H, Nekarda H, Bollschweiler E, Fink U, Helmberger H, Höfler H, Siewert JR. Sendler A, et al. Among authors: fink u. World J Surg. 1995 Jul-Aug;19(4):501-8. doi: 10.1007/BF00294710. World J Surg. 1995. PMID: 7676691 Review.

3

P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.

Schneider PM, Stoeltzing O, Roth JA, Hoelscher AH, Wegerer S, Mizumoto S, Becker K, Dittler HJ, Fink U, Siewert JR. Schneider PM, et al. Among authors: fink u. Clin Cancer Res. 2000 Aug;6(8):3153-8. Clin Cancer Res. 2000. PMID: 10955797 Clinical Trial.

4

[Prognostic factors in primary gastric non-Hodgkin's lymphoma--results of uni- and multivariate analysis].

Melcher GA, Roder JD, Fink U, Funk A, Fellbaum C, Busch R. Melcher GA, et al. Among authors: fink u. Zentralbl Chir. 1993;118(10):614-21. Zentralbl Chir. 1993. PMID: 8259731 German.

5

[Non-Hodgkin's lymphoma of the stomach, surgical therapy and prognosis].

Melcher GA, Roder JD, Fink U, Funk A, Fellbaum C, Busch R. Melcher GA, et al. Among authors: fink u. Helv Chir Acta. 1994 Apr;60(4):575-9. Helv Chir Acta. 1994. PMID: 8034536 German.

6

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.

Schneider PM, Praeuer HW, Stoeltzing O, Boehm J, Manning J, Metzger R, Fink U, Wegerer S, Hoelscher AH, Roth JA. Schneider PM, et al. Among authors: fink u. Br J Cancer. 2000 Aug;83(4):473-9. doi: 10.1054/bjoc.2000.1287. Br J Cancer. 2000. PMID: 10945494 Free PMC article.

7

Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeks.

Fromm M, Berdel WE, Schick HD, Danhauser-Riedl S, Fink U, Remy W, Reichert A, Ankele A, Präuer HW, Siewert JR, et al. Fromm M, et al. Among authors: fink u. Invest New Drugs. 1988 Sep;6(3):189-94. doi: 10.1007/BF00175396. Invest New Drugs. 1988. PMID: 3192384

8

Surgery of squamous cell carcinoma of the esophagus.

Siewert JR, Fink U, Beckurts KT, Roder JD. Siewert JR, et al. Among authors: fink u. Ann Oncol. 1994;5 Suppl 3:1-7. doi: 10.1093/annonc/5.suppl_3.s1. Ann Oncol. 1994. PMID: 8204524

9

[Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University].

Siewert JR, Bartels H, Bollschweiler E, Dittler HJ, Fink U, Hölscher AH, Roder JD. Siewert JR, et al. Among authors: fink u. Chirurg. 1992 Sep;63(9):693-700. Chirurg. 1992. PMID: 1382922 German. No abstract available.

10

[Surgery of Barrett carcinoma].

Siewert JR, Hölscher AH, Bollschweiler E, Stein HJ, Fink U. Siewert JR, et al. Among authors: fink u. Chirurg. 1994 Feb;65(2):102-9. Chirurg. 1994. PMID: 8162810 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters